A new analysis reported that more than 74,000 volunteers were affected when funding for 383 clinical studies stopped between late February and mid-August in the United States. The studies took place in medical centers that depended on national support. These projects tested treatments for cancer, heart problems, brain issues, and infectious diseases. Funding ended because of policy changes that moved resources to other goals. The report said the problem became a significant concern because the stop slowed important trials. These trials aimed to give safer medical choices and clear evidence for future care, which experts described as crucial for health research.

Experts shared that the loss of funding created many problems for volunteers. Some entered studies that did not continue, and others lost access to needed checks or medicine. Specialists added that the situation caused severe stress for centers that needed adequate support to follow strict rules. The analysis warned that unfinished studies may harm public trust and create risks for national research. A spokesperson said the agency planned new steps to fix the issue because the situation was complex and needed careful action.